Plant-derived cyclopamine vies as possible BCC treatment

January 1, 2002

Dallas - The efficacy of cyclopamine as a mechanism-based treatmentfor basal cell carcinoma is a research area that dermatologists should expectto hear more about in the future, said Stanley J. Miller, M.D., at the annualjoint meeting of the American Society for Dermatologic Surgery and the AmericanCollege of Mohs Micrographic Surgery and Cutaneous Oncology.